Shopping Cart
Remove All
Your shopping cart is currently empty
PD-1/PD-L1-IN-27 is a potent inhibitor of PD-1/PD-L1, with an IC50 of 134 nM, and demonstrates antitumor effects with minimal T cell cytotoxicity. It activates CD8+ T cells and mitigates T cell exhaustion [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,980 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,500 | 8-10 weeks | 8-10 weeks |
| Description | PD-1/PD-L1-IN-27 is a potent inhibitor of PD-1/PD-L1, with an IC50 of 134 nM, and demonstrates antitumor effects with minimal T cell cytotoxicity. It activates CD8+ T cells and mitigates T cell exhaustion [1]. |
| In vitro | Administering PD-1/PD-L1-IN-27 (compound MZ58) at concentrations of 2.5, 5, 10, and 50 µM for 48 hours shows antitumor activity with minimal cytotoxicity to T cells [1]. |
| In vivo | PD-1/PD-L1-IN-27, administered intragastrically at dosages of 10 and 25 mg/kg, exhibits an antitumor effect [1]. |
| Molecular Weight | 673.75 |
| Formula | C44H35NO6 |
| Cas No. | 2891831-47-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.